US Patent Issued to The Regents of the University of Michigan on Sept. 22 for "Methods of determining risk of and treating cancer recurrence" (Michigan Inventor)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,782, issued on Sept. 22, was assigned to The Regents of the University of Michigan (Ann Arbor, Mich.).

"Methods of determining risk of and treating cancer recurrence" was invented by Howard Petty (Ann Arbor, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are systems and methods for the prediction of recurrent cancer in a subject and systems and methods for using the prediction in the treatment or prevention of cancer recurrence."

The patent was filed on Aug. 11, 2021, under Application No. 18/041,057.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=...